Targeted reduction of VEGFR-1 expression significantly decreased the survival of breast cancer cells through downregulation of protein kinase B (AKT) phosphorylation, while targeted reduction of VEGFR-2 or NRP1 expression had no effect on the survival of these cancer cells [47]. This evidence concerns the gene FLT1 and breast carcinoma.